LETAIRIS Side Effects

7023244-1 | Gastrointestinal Disorder
on Sep 23, 2010 Female patient from UNITED STATES , weighting 290.3 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal disorder. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ZAROXOLYN (View Zaroxolyn Review and Zaroxolyn Label ), OXYGEN (View Oxygen Review and Oxygen Label ), PLO GEL (View Plo Gel Review and Plo Gel Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), BENADRYL (View Benadryl Review and Benadryl Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

7023241-6 | Blood Bilirubin Increased, Transaminases Increased
Patient was taking Letairis (View Usage). Patient had the following side effects: blood bilirubin increased, transaminases increased on Sep 23, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 171.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with VENTAVIS (View Ventavis Review and Ventavis Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), OXYGEN (View Oxygen Review and Oxygen Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), THYROID (View Thyroid Review and Thyroid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MIDODRINE HYDROCHLORIDE (View Midodrine Hydrochloride Review and Midodrine Hydrochloride Label ).

7021221-8 | Chronic Obstructive Pulmonary Disease, Lung Neoplasm Malignant
Adverse event was reported on Sep 27, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 138.1 lb, After Letairis was administered, patient had the following side effects: chronic obstructive pulmonary disease, lung neoplasm malignant. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), XOPENEX (View Xopenex Review and Xopenex Label ), CARAFATE (View Carafate Review and Carafate Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), KLOR CON (View Klor-con Review and Klor-con Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

7020716-0 | Fatigue, Oedema Peripheral
on Sep 24, 2010 Female patient from UNITED STATES , 61 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, oedema peripheral. Letairis dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NOVOLIN 70/30 (View Novolin 70/30 Review and Novolin 70/30 Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ).


7020661-0 | Systemic Lupus Erythematosus
on Sep 27, 2010 Female patient from UNITED STATES , weighting 124.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient had the following side effects: systemic lupus erythematosus. Letairis dosage: . During the same period patient was treated with TYVASO (View Tyvaso Review and Tyvaso Label ), REVATIO (View Revatio Review and Revatio Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), METHLYPREDNISONE (View Methlyprednisone Review and Methlyprednisone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DESIPRAMINE HCL (View Desipramine Hcl Review and Desipramine Hcl Label ), GERITOL (View Geritol Review and Geritol Label ). Patient was hospitalized.

7019318-1 |
Patient was taking Letairis (View Usage). on Sep 23, 2010 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 214.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), WARFARIN (View Warfarin Review and Warfarin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), COZAAR (View Cozaar Review and Cozaar Label ), POTASSIUM 10% LIQUID (View Potassium 10% Liquid Review and Potassium 10% Liquid Label ).

7019302-8 | Cardiac Failure Congestive
Adverse event was reported on Sep 20, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 70 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), ATROVENT HFA (View Atrovent Hfa Review and Atrovent Hfa Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), KLOR CON (View Klor-con Review and Klor-con Label ), XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

7019260-6 | Cardiac Failure Congestive, Emphysema
on Sep 24, 2010 Male patient from UNITED STATES , weighting 150.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient had the following side effects: cardiac failure congestive, emphysema. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LASIX (View Lasix Review and Lasix Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), DETROL LA (View Detrol La Review and Detrol La Label ). Patient was hospitalized.

7019252-7 | Lung Transplant
on Sep 28, 2010 Male patient from UNITED STATES , 59 years of age, weighting 195.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: lung transplant (What is lung transplant?). Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), WARFARIN (View Warfarin Review and Warfarin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ). Patient was hospitalized.

7019248-5 | Vertigo
Patient was taking Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: vertigo on Sep 24, 2010 from UNITED STATES Additional patient health information: Female patient , 76 years of age, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with SOTALOL (View Sotalol Review and Sotalol Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ), GLUCOSAMI/CHONDROT (View Glucosami/chondrot Review and Glucosami/chondrot Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ), LUTEIN (View Lutein Review and Lutein Label ), LOVAZA (View Lovaza Review and Lovaza Label ). Patient was hospitalized.

7019243-6 |
Adverse event was reported on Sep 28, 2010 by a Male patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 145.1 lb, . During the same period patient was treated with FLOLAN (View Flolan Review and Flolan Label ), REVATIO (View Revatio Review and Revatio Label ), OXYGEN (View Oxygen Review and Oxygen Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), BUMEX (View Bumex Review and Bumex Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

7019189-3 | Oedema, Respiratory Failure, Sleep Apnoea Syndrome
on Sep 22, 2010 Female patient from UNITED STATES , weighting 354.7 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: oedema, respiratory failure, sleep apnoea syndrome. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), BUMEX (View Bumex Review and Bumex Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ATROVENT (View Atrovent Review and Atrovent Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), PROTONIX (View Protonix Review and Protonix Label ), POTASSIUM (View Potassium Review and Potassium Label ). Patient was hospitalized.

7018978-9 |
on Sep 21, 2010 Male patient from UNITED STATES , weighting 159.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ), BROVANA (View Brovana Review and Brovana Label ).

7018907-8 | Collapse Of Lung
Patient was taking Letairis (View Usage). Patient had the following side effects: collapse of lung on Sep 24, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, weighting 157.1 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with ADCIRCA (View Adcirca Review and Adcirca Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), TRAMADOL (View Tramadol Review and Tramadol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LASIX (View Lasix Review and Lasix Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PROTONIX (View Protonix Review and Protonix Label ). Patient was hospitalized.

7017983-6 | Fatigue, Oedema Peripheral
Adverse event was reported on Sep 27, 2010 by a Female patient taking Letairis (View Usage) (Dosage: Letairis 10mg Daily Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 61 years of age, After Letairis was administered, patient had the following side effects: fatigue, oedema peripheral. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NOVOLIN 70/30 (View Novolin 70/30 Review and Novolin 70/30 Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ).

7013538-8 | Vertigo
on Sep 22, 2010 Female patient from UNITED STATES , 76 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: vertigo. Letairis dosage: . During the same period patient was treated with SOTALOL (View Sotalol Review and Sotalol Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ), GLUCOSAMI/CHONDROT (View Glucosami/chondrot Review and Glucosami/chondrot Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ), LUTEIN (View Lutein Review and Lutein Label ), LOVAZA (View Lovaza Review and Lovaza Label ). Patient was hospitalized.

7012652-0 |
on Sep 22, 2010 Male patient from UNITED STATES , 78 years of age, weighting 172.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), AMLODIPINE BESYLATE AND BENAZEPRIL HCL (View Amlodipine Besylate And Benazepril Hcl Review and Amlodipine Besylate And Benazepril Hcl Label ), ETODOLAC (View Etodolac Review and Etodolac Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ).

7010682-6 | Dyspnoea, Haemoglobin Decreased, Pulmonary Fibrosis, Pulmonary Hypertension
Patient was taking Letairis (View Usage). After Letairis was administered, patient had the following side effects: dyspnoea, haemoglobin decreased, pulmonary fibrosis (What is pulmonary fibrosis?), pulmonary hypertension (What is pulmonary hypertension?) on Sep 21, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 170.7 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with XOPENEX (View Xopenex Review and Xopenex Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), CORGARD (View Corgard Review and Corgard Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), CEPACOL (View Cepacol Review and Cepacol Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), ATIVAN (View Ativan Review and Ativan Label ), TYLENOL (View Tylenol Review and Tylenol Label ). Patient was hospitalized.

7010045-3 | Dyspnoea, Fatigue, Oedema Peripheral
Adverse event was reported on Sep 21, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 74 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, fatigue, oedema peripheral. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), PROCRIT (View Procrit Review and Procrit Label ), VICODIN (View Vicodin Review and Vicodin Label ).

7010041-6 | Cardiac Failure Congestive, Emphysema
on Sep 20, 2010 Male patient from UNITED STATES , weighting 150.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient had the following side effects: cardiac failure congestive, emphysema. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LASIX (View Lasix Review and Lasix Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), DETROL LA (View Detrol La Review and Detrol La Label ). Patient was hospitalized.

7010038-6 | Dyspnoea, Pulmonary Artery Dilatation
on Sep 20, 2010 Female patient from UNITED STATES , 82 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: dyspnoea, pulmonary artery dilatation. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), WARFARIN (View Warfarin Review and Warfarin Label ), LASIX (View Lasix Review and Lasix Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), POTASSIUM (View Potassium Review and Potassium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

7007937-8 | Pneumothorax
Patient was taking Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: pneumothorax on Sep 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 200.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LASIX (View Lasix Review and Lasix Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PROCARDIA (View Procardia Review and Procardia Label ). Patient was hospitalized.

7007362-X | Brain Herniation, Haemorrhage Intracranial
Adverse event was reported on Sep 17, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 105.1 lb, Patient had the following side effects: brain herniation, haemorrhage intracranial. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN (View Metformin Review and Metformin Label ).

7007356-4 | Cardiac Failure Congestive
on Sep 20, 2010 Male patient from UNITED STATES , weighting 214.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: cardiac failure congestive. Letairis dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), COUMADIN (View Coumadin Review and Coumadin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), COREG (View Coreg Review and Coreg Label ), COZAAR (View Cozaar Review and Cozaar Label ), PRAZOSIN HCL (View Prazosin Hcl Review and Prazosin Hcl Label ). Patient was hospitalized.

7006630-5 | No Therapeutic Response, Oedema Peripheral
on Sep 21, 2010 Female patient from UNITED STATES , 66 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: no therapeutic response, oedema peripheral. Letairis dosage: 5mg Daily Orally. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), FLONASE (View Flonase Review and Flonase Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ).

7006629-9 | Dyspnoea, Pulmonary Artery Dilatation
Patient was taking Letairis (View Usage). Patient had the following side effects: dyspnoea, pulmonary artery dilatation on Sep 21, 2010 from UNITED STATES Additional patient health information: Female patient , 82 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Letairis dosage: 5mg Daily Orally. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), AMYTRIPTYLINE (View Amytriptyline Review and Amytriptyline Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LASIX (View Lasix Review and Lasix Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), WARFARIN (View Warfarin Review and Warfarin Label ), POTASSIUM (View Potassium Review and Potassium Label ).

7006608-1 | Cardiac Failure Congestive
Adverse event was reported on Sep 21, 2010 by a Female patient taking Letairis (View Usage) (Dosage: 5mg Daily Orally) . Location: UNITED STATES , 70 years of age, After Letairis was administered, patient had the following side effects: cardiac failure congestive. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), WARFARIN (View Warfarin Review and Warfarin Label ), ATROVENT HFA (View Atrovent Hfa Review and Atrovent Hfa Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), KLOR CON (View Klor-con Review and Klor-con Label ). Patient was hospitalized.

7006530-0 | Cardiac Failure Congestive, Condition Aggravated, Deep Vein Thrombosis
on Sep 21, 2010 Female patient from UNITED STATES , 49 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, condition aggravated, deep vein thrombosis (What is deep vein thrombosis?). Letairis dosage: 5mg Daily Oral. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), LASIX (View Lasix Review and Lasix Label ), WARFARIN (View Warfarin Review and Warfarin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), REVATIO (View Revatio Review and Revatio Label ).

7006474-4 | Intestinal Obstruction
on Sep 16, 2010 Female patient from UNITED STATES , 81 years of age, weighting 109.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient had the following side effects: intestinal obstruction. Letairis dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), XYZAL (View Xyzal Review and Xyzal Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), REGLAN (View Reglan Review and Reglan Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

7006445-8 |
Patient was taking Letairis (View Usage). on Sep 15, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 171.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with VENTAVIS (View Ventavis Review and Ventavis Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), OXYGEN (View Oxygen Review and Oxygen Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), THYROID (View Thyroid Review and Thyroid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MIDODRINE HYDROCHLORIDE (View Midodrine Hydrochloride Review and Midodrine Hydrochloride Label ).

7005337-8 |
Adverse event was reported on Sep 15, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 147.1 lb, . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ZOCOR (View Zocor Review and Zocor Label ), MIDODRINE HYDROCHLORIDE (View Midodrine Hydrochloride Review and Midodrine Hydrochloride Label ), OXYCODONE HCL AND ACETAMINOPHEN (View Oxycodone Hcl And Acetaminophen Review and Oxycodone Hcl And Acetaminophen Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PROTONIX (View Protonix Review and Protonix Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

7002591-3 |
on Sep 13, 2010 Female patient from UNITED STATES , weighting 138.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), CARAFATE (View Carafate Review and Carafate Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), KLOR CON (View Klor-con Review and Klor-con Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

7000610-1 | Pulmonary Arterial Hypertension
on Sep 14, 2010 Female patient from UNITED STATES , weighting 187.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: pulmonary arterial hypertension. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LASIX (View Lasix Review and Lasix Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), BUMEX (View Bumex Review and Bumex Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), LANTUS (View Lantus Review and Lantus Label ), VALIUM (View Valium Review and Valium Label ), ELAVIL (View Elavil Review and Elavil Label ).

7000342-X |
Patient was taking Letairis (View Usage). on Sep 15, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 132.1 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), DIOVAN (View Diovan Review and Diovan Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), JANUVIA (View Januvia Review and Januvia Label ), PRANDIN (View Prandin Review and Prandin Label ).

6994533-1 | Hiv Infection, Sepsis
Adverse event was reported on Sep 13, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 138.1 lb, Patient had the following side effects: hiv infection (What is hiv infection?), sepsis (What is sepsis?). During the same period patient was treated with PEPCID (View Pepcid Review and Pepcid Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), BENADRYL (View Benadryl Review and Benadryl Label ), REYATAZ (View Reyataz Review and Reyataz Label ), LASIX (View Lasix Review and Lasix Label ), TRICOR (View Tricor Review and Tricor Label ), NORVIR (View Norvir Review and Norvir Label ).

6994313-7 | Chest Pain, Dyspnoea, Oedema
on Sep 14, 2010 Female patient from UNITED STATES , 87 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). After Letairis was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea, oedema. Letairis dosage: . Patient was hospitalized.

6994312-5 |
on Sep 13, 2010 Female patient from UNITED STATES , 72 years of age, weighting 163.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), XOPENEX (View Xopenex Review and Xopenex Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), CENTRUM CALCIUM (View Centrum Calcium Review and Centrum Calcium Label ).

6992857-5 | Cardiac Failure, Electrolyte Imbalance, Pulmonary Hypertension, Renal Failure Acute
Patient was taking Letairis (View Usage). Patient had the following side effects: cardiac failure, electrolyte imbalance, pulmonary hypertension (What is pulmonary hypertension?), renal failure acute on Sep 09, 2010 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with FLOLAN (View Flolan Review and Flolan Label ). Patient was hospitalized.

6989336-8 | Pregnancy, Pulmonary Arterial Hypertension
Adverse event was reported on Sep 13, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 165.3 lb, After Letairis was administered, patient had the following side effects: pregnancy (What is pregnancy?), pulmonary arterial hypertension. During the same period patient was treated with FLOLAN (View Flolan Review and Flolan Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LORTAB (View Lortab Review and Lortab Label ).

6985127-2 | Pneumonia, Syncope
on Sep 13, 2010 Female patient from UNITED STATES , 48 years of age, weighting 137.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), syncope. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), ZANTAC (View Zantac Review and Zantac Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), VICODIN (View Vicodin Review and Vicodin Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized.

6985118-1 | Rectal Haemorrhage
on Sep 10, 2010 Female patient from UNITED STATES , weighting 209.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient had the following side effects: rectal haemorrhage. Letairis dosage: . During the same period patient was treated with VENTAVIS (View Ventavis Review and Ventavis Label ), REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

6985115-6 | Emphysema
Patient was taking Letairis (View Usage). After Letairis was administered, patient had the following side effects: emphysema on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 150.1 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LASIX (View Lasix Review and Lasix Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), DETROL LA (View Detrol La Review and Detrol La Label ). Patient was hospitalized.

6982345-4 |
Adverse event was reported on Sep 12, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 132.1 lb, . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), DIOVAN (View Diovan Review and Diovan Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), JANUVIA (View Januvia Review and Januvia Label ), PRANDIN (View Prandin Review and Prandin Label ).

6981586-X | Renal Failure
on Sep 10, 2010 Female patient from UNITED STATES , 51 years of age, weighting 294.3 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). Patient had the following side effects: renal failure. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), SINGULAIR (View Singulair Review and Singulair Label ), MICRO K (View Micro-k Review and Micro-k Label ). Patient was hospitalized.

6981555-X |
on Sep 09, 2010 Female patient from UNITED STATES , weighting 101.5 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with TYVASO (View Tyvaso Review and Tyvaso Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ASTELIN (View Astelin Review and Astelin Label ), XOPENEX (View Xopenex Review and Xopenex Label ), ZYRTEC D 12 HOUR (View Zyrtec-d 12 Hour Review and Zyrtec-d 12 Hour Label ), PATANOL (View Patanol Review and Patanol Label ).

6981543-3 |
Patient was taking Letairis (View Usage). on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 187.2 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LASIX (View Lasix Review and Lasix Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), BUMEX (View Bumex Review and Bumex Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), LANTUS (View Lantus Review and Lantus Label ), VALIUM (View Valium Review and Valium Label ), ELAVIL (View Elavil Review and Elavil Label ).

6981473-7 | Dyspnoea, Haemoglobin Decreased, Pulmonary Fibrosis
Adverse event was reported on Sep 09, 2010 by a Female patient taking Letairis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 170.7 lb, Patient had the following side effects: dyspnoea, haemoglobin decreased, pulmonary fibrosis (What is pulmonary fibrosis?). During the same period patient was treated with XOPENEX (View Xopenex Review and Xopenex Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), CORGARD (View Corgard Review and Corgard Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), CEPACOL (View Cepacol Review and Cepacol Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), ATIVAN (View Ativan Review and Ativan Label ), TYLENOL (View Tylenol Review and Tylenol Label ). Patient was hospitalized.

6981462-2 |
on Sep 10, 2010 Male patient from UNITED STATES , weighting 145.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ), XANAX (View Xanax Review and Xanax Label ), PAXIL (View Paxil Review and Paxil Label ), LASIX (View Lasix Review and Lasix Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), NICOTINE (View Nicotine Review and Nicotine Label ), NOVOLOG (View Novolog Review and Novolog Label ).

6980675-3 |
on Sep 09, 2010 Female patient from UNITED STATES , 73 years of age, weighting 189.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Letairis (View Usage). . Letairis dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), COMBIVENT (View Combivent Review and Combivent Label ), ZOLOFT (View Zoloft Review and Zoloft Label ).

6979598-5 |
Patient was taking Letairis (View Usage). on Sep 07, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 147.1 lb, was diagnosed with pulmonary arterial hypertension and. Letairis dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ZOCOR (View Zocor Review and Zocor Label ), MIDODRINE HYDROCHLORIDE (View Midodrine Hydrochloride Review and Midodrine Hydrochloride Label ), OXYCODONE HCL AND ACETAMINOPHEN (View Oxycodone Hcl And Acetaminophen Review and Oxycodone Hcl And Acetaminophen Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PROTONIX (View Protonix Review and Protonix Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).